U.S., Nov. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07229534) titled 'Clinical Trial to Evaluate the Efficacy and Safety of DA-5218 in Patients With Type 2 Diabetes' on Nov. 13.
Brief Summary: This study is a multicenter, double-blind, active-controlled, randomized, parallel, phase IV clinical trial to evaluate the efficacy and safety of DA-5218 in patients with type 2 diabetes who have inadequate glycemic control with metformin
Study Start Date: Nov., 2025
Study Type: INTERVENTIONAL
Condition:
Diabete Mellitus
Intervention:
DRUG: DA-5218
DA-5218 + DA-5218-C placebo
DRUG: DA-5218-C
DA-5218-C + DA-5218 placebo
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Dong-A ST Co., Ltd.
Published by ...